YM BioSciences (YM.TO)' Subsidary Resolves Proposed Arbitration with Oncoscience AG
6/29/2009 10:32:14 AM
More...
|
YM BioSciences (YM.TO) Subsidary Notifies Oncoscience AG of Intention to Submit Issues for Arbitration
11/17/2008 10:42:31 AM
More...
|
YM BioSciences (YM.TO)', European Partner, Oncoscience AG, Announces Initiation Of Advanced Nimotuzumab Trials In Adult Glioma And Pancreatic Cancer
8/21/2007 7:37:40 AM
More...
|
Oncoscience AG Announces Completion of Patient Enrollment in Phase 3 Trial
8/15/2007 8:07:46 AM
More...
|
YM BioSciences (YM.TO)' Partner, Oncoscience AG, Commences Patient Treatment In Phase III Trial In Germany With Nimotuzumab
4/27/2006 10:21:37 AM
More...
|
YM BioSciences (YM.TO)' Partner, Oncoscience AG, Cleared For Phase III Trial In Germany With Nimotuzumab
3/28/2006 10:27:00 AM
More...
|
YM BioSciences' (YM.TO) TheraCIM Receives Investigator Sponsored IND From FDA
10/19/2005 5:13:02 PM
More...
|
YM BioSciences (YM.TO) Partner, Oncoscience AG, Reports Update Of Pediatric Brain Cancer Data
10/19/2005 5:12:58 PM
More...
|
YM BioSciences (YM.TO) And Oncoscience AG Report Response Rate Of 35.3% In Pediatric Glioma
10/19/2005 5:12:52 PM
More...
|
YM BioSciences (YM.TO) And Oncoscience AG Achieve Clinical Milestone
10/19/2005 5:12:32 PM
More...
|
|